DCIS Precision
  • Consortium
  • General Public
  • Scientific Community
  • Publications
  • Home
  • News
  • Contact
  • Clinical Trials
  • |
  • NL
Select Page

Challenging the current dogma: DCIS – a precursor lesion, a risk lesion or both for subsequent invasive breast cancer?

by MSdcisPrecision345af2af1 | Jun 9, 2022 | Home News Item #2, News

Women with DCIS may develop invasive breast cancer in the same breast despite treatment. To study whether DCIS is the true precursor of all subsequent ipsilateral invasive breast cancer, PRECISION scientists compared the genetic changes in women with an initial DCIS...

More News

  • Low-Risk DCIS Research Update and Resources by PRECISION Patient Advocates
  • Challenging the current dogma: DCIS – a precursor lesion, a risk lesion or both for subsequent invasive breast cancer?
  • PRECISION researcher wins prestigious Veni Grant awarded by the Dutch Research Council (NWO)
  • Can invasive treatment be avoided for patients diagnosed with DCIS?
  • PRECISION launches a Series of Plain Language Summaries
  • PRECISION publishes its second newsletter
  • 5th World Congress on Controversies in Breast Cancer (CoBrCa 2019, San Francisco)
  • 2nd PRECISION Annual Meeting 13-14 June 2019
  • Feiten en Vragen LORD studie
  • PRECISION publishes it’s first newsletter
  • PRECISION publishes review article – Ductal carcinoma in situ: to treat or not to treat, that is the question
  • Becoming Professor…
  • ‘Over-diagnosis and over-treatment of breast cancer is a travesty in women’s healthcare’
  • PRECISION @ Association of Breast Surgery Conference 2019 – Future Management of DCIS
  • DCIS Dilemmas – clinician and patient advocate interactive session 13th June, NKI, Amsterdam
©2026 DCISprecision.org | Design by Mediaschip | FAQ | Cookie Policy